Literature DB >> 3192269

The role of complement in the stimulation of lysosomal enzyme release by polymorphonuclear leucocytes induced by immune complexes of IgG and of IgM.

Y M Lucisano1, B Mantovani.   

Abstract

The effect of complement components incorporated into precipitated immune complexes (IC) of IgG or of IgM on their capacity for stimulating lysosomal enzyme release from rabbit polymorphonuclear leucocytes was studied in vitro. We have found that: (i) complement causes an amplification in the stimulatory capacity of both classes of IC, the effect being dependent on the concentration of the IC, and higher for the IgM class; (ii) dose-effect experiments of competition by fluid-phase immunoglobulins have shown that IgG (in physiological or smaller concentrations) can inhibit greatly the stimulation by this class of immune complex; this inhibition can be prevented, however, by the presence of complement in the IC (a situation expected to occur in vivo); for IgM immune complexes there was no such competitive inhibition, so complement would not be necessary; (iii) the relevant complement factors must be located in the range C1-C3. These results help us to understand the importance of complement (besides the well-known generation of chemotactic factors) in the mechanisms of tissue injury produced by neutrophils in immune complex diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192269      PMCID: PMC1384909     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes.

Authors:  B Mantovani
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

2.  A MICRO-BIURET METHOD FOR ESTIMATING PROTEINS.

Authors:  R F ITZHAKI; D M GILL
Journal:  Anal Biochem       Date:  1964-12       Impact factor: 3.365

3.  Redistribution of immunoglobulin receptors on human neutrophils and its relationship to the release of lysosomal enzymes;.

Authors:  A N Sajnani; N S Ranadive; H Z Movat
Journal:  Lab Invest       Date:  1976-08       Impact factor: 5.662

Review 4.  Immunologic tissue injury mediated by neutrophilic leukocytes.

Authors:  C G Cochrane
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

5.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

Review 6.  Membrane receptors on neutrophils.

Authors:  P M Henson
Journal:  Immunol Commun       Date:  1976

7.  Characterization of surface receptors on bovine leukocytes.

Authors:  A S Grewal; B T Rouse; L A Babiuk
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

8.  The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.

Authors:  J W Goers; R R Porter
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

9.  The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses.

Authors:  P M Henson; H B Johnson; H L Spiegelberg
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

10.  Lung injury produced by immune complexes of varying composition.

Authors:  H Scherzer; P A Ward
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

View more
  2 in total

1.  A systematic study of neutrophil degranulation and respiratory burst in vitro by defined immune complexes.

Authors:  W Zhang; J Voice; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

Review 2.  Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products.

Authors:  Adriana Balbina Paoliello-Paschoalato; Larissa Fávaro Marchi; Micássio Fernandes de Andrade; Luciana Mariko Kabeya; Eduardo Antônio Donadi; Yara Maria Lucisano-Valim
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.